IL282390A - Formulations of adiponectin peptidomimetics - Google Patents
Formulations of adiponectin peptidomimeticsInfo
- Publication number
- IL282390A IL282390A IL282390A IL28239021A IL282390A IL 282390 A IL282390 A IL 282390A IL 282390 A IL282390 A IL 282390A IL 28239021 A IL28239021 A IL 28239021A IL 282390 A IL282390 A IL 282390A
- Authority
- IL
- Israel
- Prior art keywords
- formulations
- adiponectin peptidomimetics
- adiponectin
- peptidomimetics
- peptidomimetics formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749861P | 2018-10-24 | 2018-10-24 | |
| PCT/US2019/057876 WO2020086856A1 (en) | 2018-10-24 | 2019-10-24 | Adiponectin peptidomimetics formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL282390A true IL282390A (en) | 2021-06-30 |
Family
ID=70326409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL282390A IL282390A (en) | 2018-10-24 | 2021-04-18 | Formulations of adiponectin peptidomimetics |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12201668B2 (enExample) |
| EP (1) | EP3870204A4 (enExample) |
| JP (2) | JP7688471B2 (enExample) |
| KR (1) | KR20210118810A (enExample) |
| CN (1) | CN113164551A (enExample) |
| AU (1) | AU2019363588A1 (enExample) |
| CA (1) | CA3116065A1 (enExample) |
| IL (1) | IL282390A (enExample) |
| SG (1) | SG11202103947XA (enExample) |
| TW (1) | TWI921299B (enExample) |
| WO (1) | WO2020086856A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113164551A (zh) * | 2018-10-24 | 2021-07-23 | 雅利斯塔制药公司 | 脂联素肽模拟物制剂 |
| US20240382564A1 (en) * | 2023-04-17 | 2024-11-21 | Allysta Pharmaceuticals, Inc. | Methods and Compositions for Treating Muscular Dystrophy and Memory Impairment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69333850T3 (de) * | 1992-05-06 | 2011-03-17 | Alcon Laboratories, Inc., Fort Worth | Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen |
| US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
| US11078262B2 (en) * | 2007-04-30 | 2021-08-03 | Allergan, Inc. | High viscosity macromolecular compositions for treating ocular conditions |
| WO2012142142A2 (en) * | 2011-04-12 | 2012-10-18 | Temple University - Of The Commonwealth System Higher Education | Adiponectin receptor agonists and methods of use |
| KR101438744B1 (ko) * | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| AU2015317531B2 (en) * | 2014-09-17 | 2020-11-19 | Panoptica, Inc. | Ocular formulations for drug-delivery and protection of the anterior segment of the eye |
| JP2018503595A (ja) | 2014-09-24 | 2018-02-08 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子およびその製剤 |
| ES2903448T3 (es) | 2015-05-01 | 2022-04-01 | Allysta Pharmaceuticals Inc | Peptidomiméticos de adiponectina para el tratamiento de trastornos oculares |
| CN113164551A (zh) * | 2018-10-24 | 2021-07-23 | 雅利斯塔制药公司 | 脂联素肽模拟物制剂 |
-
2019
- 2019-10-24 CN CN201980070344.0A patent/CN113164551A/zh active Pending
- 2019-10-24 CA CA3116065A patent/CA3116065A1/en active Pending
- 2019-10-24 EP EP19876498.7A patent/EP3870204A4/en active Pending
- 2019-10-24 JP JP2021522507A patent/JP7688471B2/ja active Active
- 2019-10-24 WO PCT/US2019/057876 patent/WO2020086856A1/en not_active Ceased
- 2019-10-24 SG SG11202103947XA patent/SG11202103947XA/en unknown
- 2019-10-24 AU AU2019363588A patent/AU2019363588A1/en not_active Abandoned
- 2019-10-24 KR KR1020217015336A patent/KR20210118810A/ko not_active Ceased
- 2019-10-24 TW TW108138490A patent/TWI921299B/zh active
- 2019-10-24 US US16/662,932 patent/US12201668B2/en active Active
-
2021
- 2021-04-18 IL IL282390A patent/IL282390A/en unknown
-
2024
- 2024-09-17 JP JP2024160067A patent/JP2024178262A/ja active Pending
- 2024-12-10 US US18/976,132 patent/US20250099533A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019363588A1 (en) | 2021-05-13 |
| TWI921299B (zh) | 2026-04-11 |
| US20200129585A1 (en) | 2020-04-30 |
| JP7688471B2 (ja) | 2025-06-04 |
| EP3870204A1 (en) | 2021-09-01 |
| SG11202103947XA (en) | 2021-05-28 |
| JP2022505832A (ja) | 2022-01-14 |
| KR20210118810A (ko) | 2021-10-01 |
| US20250099533A1 (en) | 2025-03-27 |
| JP2024178262A (ja) | 2024-12-24 |
| WO2020086856A1 (en) | 2020-04-30 |
| US12201668B2 (en) | 2025-01-21 |
| CA3116065A1 (en) | 2020-04-30 |
| CN113164551A (zh) | 2021-07-23 |
| TW202033213A (zh) | 2020-09-16 |
| EP3870204A4 (en) | 2022-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282617A (en) | Aerosol formulation | |
| IL282567A (en) | Aerosol formulation | |
| IL282523A (en) | Aerosol formulation | |
| GB201811100D0 (en) | Composition | |
| GB201809976D0 (en) | Novel formulations | |
| GB201810492D0 (en) | Composition | |
| IL282589A (en) | Aerosol formulation | |
| GB201816447D0 (en) | Formulation | |
| GB201801614D0 (en) | Formulation | |
| IL282461A (en) | Aerosol formulation | |
| GB201804434D0 (en) | Composition | |
| IL282697A (en) | Aerosol formulation | |
| GB201817863D0 (en) | Aerosolisable formulation | |
| GB201812145D0 (en) | Composition | |
| GB201801596D0 (en) | Composition | |
| SG11202103947XA (en) | Adiponectin peptidomimetics formulations | |
| GB201813229D0 (en) | Formulation | |
| GB201811926D0 (en) | Aerosolisable formulation | |
| GB201810024D0 (en) | Composition | |
| GB201807312D0 (en) | Formulation | |
| GB201809123D0 (en) | Composition | |
| SG11202011823SA (en) | Activator-nucleator formulations | |
| GB201819028D0 (en) | Butanol-based formulations | |
| GB201808386D0 (en) | Formulations | |
| GB201804545D0 (en) | Formulations |